Bellerophon Therapeutics, Inc. (BLPH) has 20 known insider and institutional holders on record. The largest holder is Puissance Cross-Border Opportunities III LLC with 8,298,755 shares. Other notable holders include VENROCK ASSOCIATES IV L P and Linde North America, Inc..
BLPH Insider Ownership
Top Holder
Puissance Cross-Border Opportunities III LLC
8,298,755 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Puissance Cross-border Opportunities Iii Llc |
10 Percent Owner |
8,298,755 |
2018-04-13 |
|
| 2 |
Venrock Associates Iv L P |
10 Percent Owner |
6,824,425 |
2019-10-28 |
|
| 3 |
Linde North America, Inc. |
10 Percent Owner |
1,920,000 |
2018-01-02 |
|
| 4 |
Puissance Life Science Opportunities Fund Vi |
10 Percent Owner |
1,076,841 |
2023-06-07 |
|
| 5 |
Nelsen Robert |
10 Percent Owner |
965,660 |
2015-02-23 |
|
| 6 |
Arch Venture Fund Vi Lp |
10 Percent Owner |
965,660 |
2015-02-23 |
|
| 7 |
New Mountain Investments Ii, Llc |
10 Percent Owner |
609,231 |
2021-03-22 |
|
| 8 |
Edmonds Amy |
VP Clinical Operations & Admin |
445,886 |
2019-09-30 |
|
| 9 |
Tenenbaum Fabian |
Chief Executive Officer |
407,459 |
2019-11-19 |
|
| 10 |
Amin Naseem |
Director |
291,865 |
2023-06-09 |
|
| 11 |
Tasse Daniel |
Director |
182,604 |
2018-06-25 |
|
| 12 |
Peacock Jonathan M |
Director |
157,033 |
2021-04-02 |
|
| 13 |
Fernandes Peter |
See Remarks |
100,000 |
2023-06-09 |
|
| 14 |
Agrawal Amit |
Chief Operating Officer |
100,000 |
2015-07-13 |
|
| 15 |
Luehring Jens |
Director |
95,213 |
2018-06-25 |
|
| 16 |
Quinn Deborah |
Chief Medical Officer |
94,070 |
2018-06-14 |
|
| 17 |
Korner Assaf |
CFO |
66,078 |
2019-11-19 |
|
| 18 |
Laccona Nicholas |
Financial Officer, (pfo & Pao) |
50,000 |
2023-02-14 |
|
| 19 |
Shah Parag Suresh |
VP of Business Operations |
50,000 |
2023-06-09 |
|
| 20 |
Dekker Martin |
See Remarks |
50,000 |
2023-06-09 |
|
No ownership data available for BLPH.
